MDCPX
Price
$27.02
Change
-$0.22 (-0.81%)
Updated
Jun 13 closing price
Net Assets
1.65B
RLBCX
Price
$35.41
Change
-$0.31 (-0.87%)
Updated
Jun 13 closing price
Net Assets
244.39B
Interact to see
Advertisement

MDCPX vs RLBCX

Header iconMDCPX vs RLBCX Comparison
Open Charts MDCPX vs RLBCXBanner chart's image
BlackRock Balanced Investor A
Price$27.02
Change-$0.22 (-0.81%)
VolumeN/A
Net Assets1.65B
American Funds American Balanced R3
Price$35.41
Change-$0.31 (-0.87%)
VolumeN/A
Net Assets244.39B
MDCPX vs RLBCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MDCPX vs. RLBCX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDCPX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 244B vs. MDCPX (1.65B). MDCPX pays higher dividends than RLBCX: MDCPX (3.68) vs RLBCX (1.63). MDCPX was incepted earlier than RLBCX: MDCPX (31 years) vs RLBCX (23 years). RLBCX (0.89) is less costly to investors than MDCPX (0.81). MDCPX is a more actively managed with annual turnover of: 127.00 vs. RLBCX (44.00). RLBCX has a lower initial minimum investment than MDCPX: RLBCX (250) vs MDCPX (1000). MDCPX annual gain was more profitable for investors over the last year : 5.23 vs. RLBCX (4.94). RLBCX return over 5 years is better than : 36.51 vs. MDCPX (27.06).
MDCPXRLBCXMDCPX / RLBCX
Total Expense Ratio0.790.8989%
Annual Report Gross Expense Ratio0.810.8991%
Fund Existence31 years23 years-
Gain YTD4.8914.294114%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.65B244B1%
Annual Yield % from dividends3.681.63225%
Returns for 1 year5.234.94106%
Returns for 3 years30.9031.5498%
Returns for 5 years27.0636.5174%
Returns for 10 years28.3454.9952%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLTX44.210.19
+0.43%
MoonLake Immunotherapeutics
NOVA0.22N/A
N/A
Sunnova Energy International
XTNT0.62-0.03
-4.23%
Xtant Medical Holdings
FND73.63-3.40
-4.41%
Floor & Decor Holdings
EZGO0.36-0.02
-4.65%
EZGO Technologies Ltd